Influenza: old and new threats
- PMID: 15577936
- DOI: 10.1038/nm1141
Influenza: old and new threats
Abstract
Influenza remains an important disease in humans and animals. In contrast to measles, smallpox and poliomyelitis, influenza is caused by viruses that undergo continuous antigenic change and that possess an animal reservoir. Thus, new epidemics and pandemics are likely to occur in the future, and eradication of the disease will be difficult to achieve. Although it is not clear whether a new pandemic is imminent, it would be prudent to take into account the lessons we have learned from studying different human and animal influenza viruses. Specifically, reconstruction of the genes of the 1918 pandemic virus and studies on their contribution to virulence will be important steps toward understanding the biological capabilities of this lethal virus. Increasing the availability of new antiviral drugs and developing superior vaccines will provide us with better approaches to control influenza and to have a positive impact on disease load. A concern is that the imposition of new rules for working with infectious influenza viruses under high security and high containment conditions will stifle scientific progress. The complex questions of what makes an influenza virus transmissible from one human to another and from one species to another, as well as how the immune system interacts with the virus, will require the active collaboration and unencumbered work of many scientific groups.
Similar articles
-
Influenza: lessons from past pandemics, warnings from current incidents.Nat Rev Microbiol. 2005 Aug;3(8):591-600. doi: 10.1038/nrmicro1208. Nat Rev Microbiol. 2005. PMID: 16064053 Review.
-
Vaccines to protect humans from pandemic avian influenza strains.Md Med. 2006 Winter;7(1):15-8. Md Med. 2006. PMID: 16613361 Review.
-
Seasonal and pandemic influenza: a 2007 update on challenges and solutions.Clin Infect Dis. 2008 Apr 1;46(7):1024-31. doi: 10.1086/528720. Clin Infect Dis. 2008. PMID: 18444819 Review.
-
Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Expert Rev Vaccines. 2007 Apr;6(2):193-201. doi: 10.1586/14760584.6.2.193. Expert Rev Vaccines. 2007. PMID: 17408369 Review.
-
Avian influenza pandemic threat and health systems response.Emerg Med Australas. 2006 Oct-Dec;18(5-6):430-43. doi: 10.1111/j.1742-6723.2006.00906.x. Emerg Med Australas. 2006. PMID: 17083631 Review.
Cited by
-
Comparative Pathology of Animal Models for Influenza A Virus Infection.Pathogens. 2023 Dec 29;13(1):35. doi: 10.3390/pathogens13010035. Pathogens. 2023. PMID: 38251342 Free PMC article. Review.
-
GlcNac produced by the gut microbiome enhances host influenza resistance by modulating NK cells.Gut Microbes. 2023 Dec;15(2):2271620. doi: 10.1080/19490976.2023.2271620. Epub 2023 Nov 12. Gut Microbes. 2023. PMID: 37953509 Free PMC article.
-
Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains.Vaccines (Basel). 2023 May 31;11(6):1050. doi: 10.3390/vaccines11061050. Vaccines (Basel). 2023. PMID: 37376439 Free PMC article.
-
Influenza pandemics and macroeconomic fluctuations 1871-2016.Cliometrica (Berl). 2023 May 29:1-47. doi: 10.1007/s11698-023-00269-w. Online ahead of print. Cliometrica (Berl). 2023. PMID: 37363694 Free PMC article.
-
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.J Virol. 2023 Jul 27;97(7):e0013523. doi: 10.1128/jvi.00135-23. Epub 2023 Jun 20. J Virol. 2023. PMID: 37338377 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
